Tag Archives: clinical trials

CSU researchers find antimalarial drugs can fight lung disease

A research team from Colorado State University has found that drugs used to treat malaria are also effective in treating a lung disease similar to tuberculosis. Their findings were featured on the cover of the February 23 issue of Science Translational Medicineone of the best scientific journals in the country. …

Read More »

MD&M West 2022 on 3D printing, biomaterials, robotics, digital health

Medical Design & Manufacturing (MD&M) West, the largest medtech event in North America and hosted annually by Informa Markets – Engineering, unveils its educational programming for Design. Engineer. To construct. Conference. Speakers include experts from Medtronic, NXT Biomedical, Canary Medical, Galen Robotics, Edward Life Sciences, Philips, Tech Coast Angels, Stryker, …

Read More »

Institute of Infectious Diseases of the Institute of Human Virology

BALTIMORE, March 3, 2022—The University of Maryland School of Medicine Institute of Human Virologya Global Virus Network (GVN) Center of excellence, physician researchers played a collaborative role in the successful transplant last month of a genetically modified pig heart into a patient with end-stage heart disease by creating strategies for …

Read More »

American Cancer Society CEO issues call to action on genitourinary cancer disparities

February 18, 2022 4 minute read Source/Disclosures Published by: Source: Knudsen KE. A way forward, a call to action: Addressing trends and disparities in genitourinary cancers. Presented at: ASCO Genitourinary Cancer Symposium; February 17-19, 2022; San Francisco. Disclosures: Knudsen does not report any relevant financial information. …

Read More »

DaVita Clinical Research Study Reveals Effectiveness of Common COVID-19 Vaccines at Parity for Patients with Kidney Failure

DENVER, February 17, 2022 /PRNewswire/ — Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) had similar rates of breakthrough infection, hospitalization and mortality as dialysis patients who received a mRNA-based vaccine (Pfizer/BioNTech), according to a DaVita Clinical Research (DCR) study published online ahead of print by …

Read More »

Talk about regenerative medicine and potential drug for COVID-19

Cymbeline “Bem” Culiat, co-founder, president and chief scientific officer of NellOne Therapeutics Inc. in Knoxville and former molecular geneticist at Oak Ridge National Laboratory, will speak virtually to Friends of ORNL at noon on Tuesday, February 8. She will talk about “Future Applications in Regenerative Medicine” and part of her …

Read More »

Mustang Bio announces targeted CAR T data for the MB-106 CD20

WORCESTER, Mass., Jan. 7, 2022 (GLOBE NEWSWIRE) – Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs into therapies cells and genes in potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that interim phase 1/2 data on MB-106, …

Read More »

Stop dementia in the nose – nasal spray to treat, prevent Alzheimer’s disease

Via repositioning the drug, Osaka City University creates a combination of rifampin and resveratrol and has shown in mouse models that nasal administration improves cognitive function without the negative liver side effects of rifampin only. Via repositioning the drug, Osaka City University creates a combination of rifampin and resveratrol and …

Read More »

Study demonstrates novel approach to target activator-dependent cancers

As researchers have identified several genes responsible for prostate cancer, a new study published in Nature reveals the puppeteer controlling the strings. The chains: carcinogenic or oncogenic genes, such as the androgen receptor, FOXA1, ERG and MYC. The Puppet Master: A chromatin remodeling complex called SWI / SNF, which controls …

Read More »

GBT supports the sickle cell disease program of the ASH Research Collaborative Data Hub

WASHINGTON and SOUTH SAN FRANCISCO, California, December 2, 2021 / PRNewswire / – The ASH Research Collaborative (ASH RC), a nonprofit organization established in 2018 by the American Society of Hematology (ASH) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) has announced today that GBT will provide a grant of …

Read More »

Vaccine efficacy and immune interference: co-administration of COVID-19 and influenza vaccines

As we move towards the second anniversary of the COVID-19 pandemic, attention widens to encompass the range of unintended health care consequences of these unprecedented times and measures. Against this background, efforts have been made to analyze the data and predict what the winter months will look like in terms …

Read More »

Cyclo Therapeutics Appoints Cynthia A. Lemere, PhD, Preeminent Neuroscientist and World Renowned Researcher, as Senior Advisor for Advancement of Alzheimer’s Disease Asset

GAINESVILLE, Florida – (COMMERCIAL THREAD) –Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical-stage biotechnology company dedicated to the development of life-changing drugs through science and innovation for patients and families living with diseases, today announced the appointment of Cynthia A. Lemere, PhD as Senior Advisor for …

Read More »

Insitu Biologics INSB200 ™ Poster Voted “Best Meeting” at American Society of Regional Anesthesia Pain Meeting | Business

WOODBURY, Minnesota – (BUSINESS WIRE) – October 28, 2021– The American Society of Regional Anesthesia has selected the INSB200 â„¢ poster from InSitu Biologics as its The best of the meeting presentation in Emerging Technologies for their 20 th Annual Pain Meeting in November 2021. The “Best of Meeting” award …

Read More »

A peer-reviewed article confirms that Qualigen’s FastPack® is

CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) – Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with orphan drug designation potential, announces today the publication of a study in the open source peer-reviewed journal, Diagnostic, validating the FastPack of the Company’s …

Read More »

XORTX announces results of COVID-19 from Mount Sinai

CALGARY, Alberta, October 14, 2021 (GLOBE NEWSWIRE) – XORTX Therapeutics Inc. (“XORTX“or the”Society“) (CSE: XRX | NASDAQ: XRTX), a therapeutic pharmaceutical company focused on developing innovative therapies to treat progressive renal failure, is pleased to announce and share the results of a summary of the American Society of Nephrology Kidney …

Read More »

Global Clinical Trial Kits Market (2021-2028)

Dublin, October 08, 2021 (GLOBE NEWSWIRE) – The Clinical Trial Kits Market Size, Share and Trend Analysis Report by Department (Kit Solutions, Logistics), by Phase (Phase I, Phase II, Phase III, Phase IV), by Region and segment forecast, 2021-2028 “ report was added to ResearchAndMarkets.com offer. The global clinical trial …

Read More »

Denali Therapeutics Announces Positive Clinical Results and Regulatory Advances for Developmental Programs in Amyotrophic Lateral Sclerosis (ALS) | Small molecules

Denali Therapeutics Announces Positive Clinical Results and Regulatory Advances for Developmental Programs in Amyotrophic Lateral Sclerosis (ALS) Details Category: Small Molecules Posted on Thursday 07 October 2021 11:15 Hits: 68 The eIF2B DNL343 activator achieved safety and biomarker objectives in a phase 1 study in healthy volunteers; a phase 1b …

Read More »

ABIONYX Pharma announces positive preclinical results in a uveitis model and launches the strategic development of the first class of biomedicines in ophthalmology based on its bio-HDL

TOULOUSE, France & LAKELAND, Michigan, October 07, 2021– (BUSINESS WIRE) – Regulatory news: ABIONYX Pharma (Paris: ABNX) (FR0012616852 – ABNX – PEA PME eligible), a new generation biotechnology company dedicated to the discovery and development of innovative therapies, announces today, after having already obtained an orphan drug designation for CER-001 …

Read More »

Osteoporosis drug may be a promising treatment

Clinical trials are underway after scientists using the advanced photon source discovered that lasofoxifene may be a safer and more effective treatment for breast cancer than the current gold standard. In 2020, 2.3 million women worldwide were diagnosed with breast cancer, according to the World Health Organization, and the disease …

Read More »

Biorprinting of human tissues for drug testing

Bio-printers that allow scientists to design complex tissues and organs. It sounds like science fiction, but not to scientists at the Alireza Mashaghi lab at the Leiden Academic Center for Drug Research. The laboratory was recently equipped with two state-of-the-art bio-printers: BioX and LumenX +. 3D and 4D bio-printed fabrics …

Read More »

Actinium announces expansion of its R&D team and facilities to accelerate research programs focused on solid tumors and novel combinations with checkpoint inhibitors and radioconjugates

NEW YORK, September 27, 2021 / PRNewswire / – Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (“Actinium” or the “Company”), a leader in the development of targeted radiation therapy for patients with unmet needs, today announced several updates on its R&D capabilities. Actinium recently completed the expansion of its New York …

Read More »

Fecal microbiota transplantation effective for recurrent infections C Difficult

New research indicates that fecal microbiota transplantation (FMT) is a viable treatment option for recurrent Clostridioides difficile infections (CDI), but less so for primary CDI. A team, led by Tanveer Singh, MD, MBBS, Departments of Medicine, Cleveland Clinic, evaluated the effectiveness of fecal microbiota transplantation versus medical treatment. Therapy Various …

Read More »

TD2 and Deep Lens Partner to Enable Diversity, Access and Faster Clinical Trial Enrollment for Community-Based Oncology Practices

Key Partnership to Connect Patients to Precision Oncology Clinical Trials and New Therapies, Accelerating Access to Promising Treatments SCOTTSDALE, Arizona, September 16, 2021– (BUSINESS WIRE) – Translational Drug Development (TD2), a leading precision oncology contract research organization (CRO), and Deep Lens have announced a strategic partnership that will improve access …

Read More »

Study opens new approach to integrate MRI in multisite pancreatic clinical trials

Researchers at Vanderbilt Diabetes Research and Training Center (DRTC) at Vanderbilt University Medical Center conducted a multi-site study that demonstrated that, when controlled and standardized, quantitative magnetic resonance imaging (MRI) of the pancreas is highly reproducible when using different MRI hardware and software in different geographic locations. This discovery opens …

Read More »

Anti-sperm antibodies tested as contraceptives in sheep

Antibodies that bind to semen could be an effective non-hormonal method of birth control, at least according to early studies in sheep, the researchers report. When researchers introduced modified human anti-sperm antibodies into sheep’s vaginas, they found a 99.9% drop in moving sperm, according to a report in Science Translational …

Read More »

Akoya Announces Publication of MITER Study, the First Multi-Institutional Analytical Demonstration of a Space Biology Workflow, in the Journal for ImmunoTherapy of Cancer

MARLBOROUGH, Mass., July 19, 2021 (GLOBE NEWSWIRE) – Akoya Biosciences Inc, (Nasdaq: AKYA) The Spatial Biology Company®, today announced that the Phenoptics â„¢ mIF solution has been used in a multi-site study to demonstrate and validate an automated end-to-end workflow that characterizes PD-1 / PD-L1 immune checkpoint signaling in tumor …

Read More »

Todos Medical to Launch EUA Authorized SARS-CoV-2 cPass

Nature Medicine publication shows neutralizing antibodies are essential in preventing or reducing the severity of COVID-19 infection, including infection with emerging variants of COVID-19 such as the Delta variant, for vaccinated populations and not vaccinated Todos now validates cPass in its highly automated CLIA / CAP lab at Provista Diagnostics …

Read More »

Swedish researchers develop urine test capable of identifying types of asthma and their severity, which could lead to improved precision medicine diagnoses

The study “shows that measurement with a urine test offers improved accuracy compared to other measurement methods, for example certain types of blood tests,” said a press release from KI. Researchers from Karolinska Institute (KI) in Sweden have developed a non-invasive urine test that can identify which type of asthma …

Read More »

Impact Factor and Immediacy Index Rise for Clinical Chemistry from Journal of AACC, Reflecting Journal’s Groundbreaking COVID-19 Research

WASHINGTON, July 1, 2021 / PRNewswire / – The AACC, a global scientific and medical professional organization dedicated to improving health through laboratory medicine, is pleased to announce that the impact factor and immediacy index of its journal Clinical chemistry increased to 8.327 and 8.729, respectively, in the 2020 Clarivate …

Read More »

Immunocore presents clinical data further characterizing the overall survival benefit of tebentafusp in metastatic uveal melanoma at the 2021 American Society of Clinical Oncology (ASCO) annual meeting

PPRESS RELEASE Immunocore presentclinical The data further characterizing the overall survival benefit of tebentafuspin metastatic uveal melanoma at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Maryland, United States, June 04, 2021) Immunocore (Nasdaq: IMCR), an advanced biotechnology company pioneering the development …

Read More »

Seattle Cancer Care Alliance (SCCA) clinicians’ clinical oncology results to be presented at ASCO’s annual meeting in 2021

SEATTLE – (COMMERCIAL THREAD) –Seattle Cancer Care Alliance (SCCA) today announced presentations from the organization’s clinicians to be presented at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting from June 4 to 8, 2021. SCCA clinicians have contributed to studies of several types of cancer spanning the entire …

Read More »

Credent’s new technological solution will be a game-changer in healthcare

During the pandemic, the diagnostics industry faced many challenges. From logistics to phlebotomists and technicians to technology, the diagnostic industry depends on different vendors to provide phlebotomists, logistics, lab technicians, technology and other services. Established in 2012 with the vision to become the leading healthcare logistics company in India, Credent …

Read More »

New Drug Developed To Prevent Infection With Coronavirus And Associated Variants Has Been Effective In Mice | The Weather Channel – Articles de The Weather Channel

Representative image (IANS) US researchers have developed a new drug that could not only prevent SARS-CoV-2 and its variants, but also treat other respiratory coronaviruses in mice. A team led by the University of Pennsylvania developed the drug diABZI, which activated the body’s innate immune response and effectively prevented severe …

Read More »

Alkermes to Host Webcast with Panel of Oncology Experts to Discuss Nemvaleukin Alfa Data Presented at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

DUBLIN, May 28, 2021 / PRNewswire / – Alkermes plc (Nasdaq: ALKS) announced today that it will host a webcast and conference call at 4:00 p.m. ET (9:00 p.m. BST) at Friday June 4, 2021 to review data updates presented at the 2021 American Society of Clinical Oncology (ASCO) Annual …

Read More »

“ Smart Toilet ” scans stool for blood, consistency

May 25, 2021 – Developing ‘smart toilet’ uses artificial intelligence to analyze stool for consistency and presence of blood – and early evidence suggests more accurate than patient self-report . Remote, automated, real-time analysis and reporting increases the likelihood that doctors will detect gastrointestinal problems sooner, investigators say. In a …

Read More »

“ Smart toilet ” with AI Scans stool for blood, consistency

Developing ‘smart toilet’ uses artificial intelligence (AI) to analyze stool for consistency and the presence of blood – and early evidence suggests it’s more accurate than patient self-report , a study reveals. Remote, automated, real-time analysis and reporting increases the likelihood that doctors will detect gastrointestinal (GI) problems sooner, investigators …

Read More »

Professional nurse: clinical trials / 1 year FTC / CLS

A Professional Nurse – Clinical Trials position (one year contract) is available with our client, Clinical Laboratory Services (CLS) of the Wits Health Consortium in Braamfontein, Johannesburg – Gauteng. Background Clinical Laboratory Services (CLS) is a division of the Wits Health Consortium (WHC) of the School of Pathology. The main …

Read More »

Ferring and Rebiotix Present Flagship Phase 3 Data Demonstrating Superior Efficacy of Investigational RBX2660 Compared to Placebo in Reducing Recurrence of C. difficile Infection

SAINT-PREX, Switzerland & ROSEVILLE, Minnesota – (BUSINESS WIRE) – Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today presented the results of the pivotal phase 3 PUNCH â„¢ CD3 clinical trial, demonstrating superior efficacy and consistent safety of single-dose RBX2660 in reducing recurrence of Clostridioides difficile infection (CDI) compared to placebo. …

Read More »

Intensity Therapeutics Announces Presentation of Two Abstracts at American Society of Clinical Oncology (ASCO) Annual Meeting 2021

Intensity Therapeutics, Inc. (“Intensity”), a clinical-stage biotechnology company developing proprietary intratumoral products to kill tumors and increase recognition of cancers by the immune system, today announced two poster presentations at the occasion of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting to be held virtually June 4-8. Title: …

Read More »

Oncopeptides Announces Three Abstracts Accepted By American Society of Clinical Oncology 2021

WALTHAM, Massachusetts, May 19, 2021 / PRNewswire / – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotechnology company focused on developing therapies for difficult-to-treat hematologic diseases, today announces that three abstracts containing data on PEPAXTO® (melphalan flufenamide, also known as melflufen) in relapsed refractory multiple myeloma, have been accepted …

Read More »

Dr Reddy’s will manufacture and sell Eli Lilly’s COVID-19, Baricitinib, in India; 5th pharmacist to do so

Dr Reddy’s Laboratories have entered into a voluntary, non-exclusive, royalty-free license agreement with the US pharmaceutical company Eli Lilly and Company for the manufacture and sale of the drug, baricitinib. Baricitinib has received a ‘restricted emergency use authorization’ from the Ministry of Health’s central standard drug control organization for use …

Read More »

Anti-COVID-19 Drug Helps Faster Inpatient Recovery and Reduces Dependence on Supplemental Oxygen – COVID-19

Image: Anti-COVID-19 drug contributes to faster recovery in hospital patients and reduces dependence on supplemental oxygen (Photo courtesy of DNA India) Anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been shown to promote faster recovery in hospital patients and reduce dependence on supplemental oxygen in clinical trials. 2-DG’s anti-COVID …

Read More »

Scholar Rock announces the publication of data from a phase 1 clinical trial evaluating apitegromab in healthy volunteers in the Journal Advances in Therapy

CAMBRIDGE, Mass .– (BUSINESS WIRE) –Scholar rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious conditions in which protein growth factors play a fundamental role, today announced that the results of its Phase 1 safety trial and the pharmacological profile of apitemograb in healthy volunteers were …

Read More »

The Hale family to accelerate pancreatic cancer research and care with one of the biggest gifts ever to the Dana-Farber Cancer Institute

BOSTON–(BUSINESS WIRE) – Continuing their family’s deep commitment to beating pancreatic cancer, Judith B. Hale, her son, Robert T. Hale, Jr., and his wife, Karen Hale, have pledged an additional $ 50 million to Dana- Farber Cancer Institute. This donation, one of the largest one-time gifts in the history of …

Read More »

OracleBio Launches GCP Image Analysis Services

GLASGOW, Scotland – (BUSINESS WIRE) – OracleBio today announced the launch of the company’s GCP image analysis services. This latest service offering strengthens the company’s position as a world leader in quantitative digital pathology, thus expanding the company’s position in the clinical market. OracleBio’s new service offering generates quantitative image …

Read More »